Recently, The Lancet - Global Health published a new randomized clinical trial showing that the use of fluvoxamine for the treatment of early diagnosis of high-risk NEOS compared with the placebo-received control group...
11-15
A clinical trial found that fluvoxamine, a common and inexpensive antidepressant--- reduced the chance of hospitalization for high-risk COVID-19 patients. The results released Wednesday could...
11-04
CNN reported on October 28 that a large study found that an inexpensive antidepressant can reduce the risk of severe COVID-19 in people at high risk. This...
11-04
According to the Associated Press in New York on October 27, researchers have found that an inexpensive antidepressant reduces infection after conducting a study on whether existing drugs can play a role in treating COVID-19.
11-04
Beijing News (reporter Wang Kara) On June 21, Lizhu Group issued an announcement that the fluvoxamine maleate tablets of lizhu pharmaceutical factory, a wholly-owned subsidiary, passed the consistency evaluation, which is also the original research drug in...
10-27
Zhitong Financial APP News, Lizhu Pharmaceutical (01513) announced that recently, the company's wholly-owned subsidiary Livzon Group Lizhu Pharmaceutical Factory (hereinafter referred to as "Lizhu Pharmaceutical Factory") received a national ...
10-27